MAP Kinase Inhibition Promotes T Cell and Anti-Tumor Activity in Combination with PD-L1 Checkpoint Blockade The authors showed that mitogen-activated protein kinase (MAPK) kinase (MEK) inhibition did profoundly block naive CD8+ T cell priming in tumor-bearing mice, but actually increased the number of effector-phenotype antigen-specific CD8+ T cells within the tumor. MEK inhibition protected tumor-infiltrating CD8+ T cells from death driven by chronic TCR stimulation while sparing cytotoxic activity. [Immunity] Abstract Control of T Cell Antigen Reactivity via Programmed TCR Downregulation Investigators found that activated CD4+ T cells, at the peak of clonal expansion, persistently downregulated their T cell antigen receptor (TCR) expression in proportion to the strength of the initial antigen recognition. [Nat Immunol] Abstract IFN-Gamma and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma The authors report that IFN-gamma and CCL2 released systemically in response to a CD40 agonist cooperate to redirect a subset of Ly6C+CCR2+ monocytes/macrophages to infiltrate tumors and deplete fibrosis. [Cancer Discov] Abstract | Press Release Dendritic Cell Vaccines Based on Immunogenic Cell Death Elicit Danger Signals and T Cell–Driven Rejection of High-Grade Glioma Researchers combined dendritic cell (DC) immunotherapy with immunogenic cell death (ICD) induced by hypericin-based photodynamic therapy. In an orthotopic high-grade glioma (HGG) mouse model involving prophylactic/curative setups, both biologically and clinically relevant versions of ICD-based DC vaccines provided strong anti-HGG survival benefit. [Sci Transl Med] Abstract | Press Release EAF2 Mediates Germinal Center B-Cell Apoptosis to Suppress Excessive Immune Responses and Prevent Autoimmunity The authors showed that ELL-associated factor 2 (EAF2) is selectively upregulated in germinal center (GC) B cells among various immune cell types and promotes apoptosis of GC B cells both in vitro and in vivo. [Nat Commun] Full Article Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain Researchers identified neurodegeneration as a potent trigger for peripheral immune cell recruitment into the mouse forebrain. Subsequent immunization with myelin oligodendrocyte glycoprotein 35–55 peptide, which induces myelin autoreactive T cells in the periphery, resulted in massive immune cell recruitment into the affected forebrain. [J Neurosci] Abstract | Press Release T Follicular Helper Expansion and Humoral-Mediated Rejection Are Independent of the HVEM/BTLA Pathway Scientists assessed the role of the herpesvirus entry mediator/B- and T-lymphocyte attenuator (HVEM/BTLA) signaling pathway in the context of antibody-mediated allograft rejection. [Cell Mol Immunol] Abstract CD19xCD3 DART Protein Mediates Human B-Cell Depletion In Vivo in Humanized BLT Mice Scientists present findings of specific and systemic human B-cell depletion by a CD19xCD3 dual-affinity re-targeting (DART) protein in humanized BLT mice. Administration of the CD19xCD3 DART protein resulted in a dramatic sustained depletion of human CD19+ B cells from the peripheral blood, as well as a dramatic systemic reduction of human CD19+ B-cell levels in all tissues analyzed. [Mol Ther Oncolytics] Full Article Don’t forget to subscribe to Human Immunology News and Immunology of Infectious Disease News! |